GlassScriptPhysician profile
Kerwin S Dunham
NPI 1598116014
$1,177.69
in general payments reported to CMS, 2019-2025
7 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.69 · 2020: $22.95 · 2021: $96.69 · 2022: $270 · 2023: $564 · 2024: $47.35 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $398 · Food and Beverage: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $397.70 |
| Food and Beverage | $324.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $816.40 | 2021-2023 | Infinity, Prophecy |
| Medtronic, INC. | $109.91 | 2023-2025 | Inceptiv, Intellis Adaptivestim |
| Wright Medical Technology, INC. | $88.64 | 2019-2020 | |
| Averitas Pharma INC. | $59.49 | 2023-2025 | Qutenza |
| Integra Lifesciences Corporation | $45.81 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Titan Surgical Group, LLC | $32.16 | 2024 | |
| Tenex Health INC. | $25.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerwin Dunham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.